Deutsche Bank Initiates Pfizer With Buy

Analysts at Deutsche Bank initiated coverage on Pfizer

with a Buy rating. The target price for Pfizer is set to $34. Pfizer shares have gained 4.32% over the past 52 weeks, while the S&P 500 index has surged 22.66% in the same period. Pfizer's shares rose 1.04% to close at $29.21 yesterday.